Dr. Wirginia KrzyΕciak | Pharmacology, Toxicology and Pharmaceutical Science | Women Researcher Award
Acting Head of Department of Medical Diagnostics at the Faculty of Pharmacy of the Medical College of the Jagiellonian University in Krakow, Poland
Dr. Wirginia KrzyΕciak is a distinguished researcher and academic leader in the field of medical diagnostics, currently serving as the Acting Head of the Department of Medical Diagnostics at the Jagiellonian University Medical College (JU MC) in Poland. With a career spanning over a decade, she has made significant contributions to the study of schizophrenia, clinical biochemistry, and the relationship between oral microbiota and brain function π§ . A prolific author with 85 original scientific papers and a strong h-index of 16, Dr. KrzyΕciakβs work is highly regarded in both national and international academic circles π. She also serves on the editorial boards of several high-impact scientific journals, focusing on biostatistics, brain diseases, and biomolecules related to biofilm diseases. Beyond her research, she is actively involved in mentoring, having supervised numerous masterβs and doctoral theses π.
Professional profile
Educationπ
Dr. Wirginia KrzyΕciak has a rich academic background rooted in the medical and pharmaceutical sciences. She earned her Doctoral Degree in Medical Sciences, specializing in clinical biochemistry from Jagiellonian University Medical College (JU MC) in 2009 π. In 2018, she achieved her habilitation in Pharmaceutical Science, a prestigious qualification marking her academic excellence and expertise. Dr. KrzyΕciakβs education has laid a strong foundation for her research endeavors in schizophrenia and clinical diagnostics. She has also contributed to academic literature, authoring numerous papers and chapters in textbooks π. Her academic qualifications are further bolstered by her active membership in several scientific societies, including the Polish Microbiology Society and the Polish Biochemistry Society. Through her education, Dr. KrzyΕciak has gained deep insights into the biochemical and molecular aspects of schizophrenia, positioning her as a leading researcher in her field π¬.
Professional ExperienceποΈ
Dr. Wirginia KrzyΕciak has over a decade of professional experience in the fields of medical diagnostics and clinical biochemistry. Since 2010, she has held various academic positions at Jagiellonian University Medical College (JU MC), starting as an Assistant and later becoming an Adjunct in the Department of Medical Diagnostics π§βπ¬. She is currently the Acting Head of the Department, where she leads cutting-edge research on schizophrenia and biomolecular diagnostics. Beyond her academic role, Dr. KrzyΕciak is an expert consultant for the Central Medical Laboratory in Bytom π₯. Her leadership extends to numerous research projects, including those focused on oral microbiota and brain function. Dr. KrzyΕciak is also deeply involved in mentoring, having supervised 25 masterβs theses and two doctoral dissertations π. Her comprehensive experience in research, diagnostics, and teaching makes her a key figure in the field of clinical biochemistry and pharmaceutical sciences.
Research Interestπ
Dr. Wirginia KrzyΕciakβs research interests are centered on the intersection of clinical biochemistry, medical diagnostics, and neuroscience π§ . She has made significant contributions to understanding the biochemical and molecular underpinnings of schizophrenia, focusing on the relationship between oral microbiota and brain function, oxidative stress, and metabolic imbalances π§ͺ. Her recent projects explore innovative diagnostic biomarkers, particularly in brain diseases and biofilm-related infections, which hold promise for personalized medical approaches. Additionally, Dr. KrzyΕciak is intrigued by the role of acid stress in central nervous system disorders and the potential therapeutic interventions targeting these pathways. As the principal investigator in multiple national and international research projects, she continues to explore the frontiers of medical diagnostics, aiming to improve individualized patient care through cutting-edge biostatistical and biochemical methodologies π¬. Her research portfolio reflects a multidisciplinary approach, integrating pharmaceutical sciences with clinical applications for psychiatric conditions like schizophrenia.
Awards and Honorsπ
Dr. Wirginia KrzyΕciak has received numerous prestigious awards and honors throughout her career π. In 2024, she was awarded the Rectorβs Award for Scientific Achievements, recognizing her outstanding contributions to the field of medical diagnostics. The previous year, she received the Bronze Medal for Long Service, acknowledging her decade-long dedication to academia π . She has also been recognized multiple times by the Faculty of Pharmacy at Jagiellonian University Medical College, receiving the Deanβs Award for Scientific Achievements in 2022. Earlier in her career, she earned the Badge of the Krakow branch of the Polish Society of Microbiologists in 2017. Dr. KrzyΕciakβs accomplishments are a testament to her dedication to scientific research, mentorship, and academic leadership. Her continuous commitment to advancing medical diagnostics, especially in schizophrenia research, has earned her a strong reputation in the scientific community π§¬.
Conclusion:
Dr. Wirginia KrzyΕciak is an outstanding candidate for the Women Researcher Award. Her extensive experience, significant contributions to schizophrenia research, and leadership roles within academia make her a strong contender. She has demonstrated scientific excellence, international collaboration, and research leadership. However, focusing more on initiatives supporting women in science and engaging more broadly with the public could enhance her profile for this specific award.
Publications top notedπ
- From Periphery Immunity to Central Domain Through Clinical Interview as a New Insight on Schizophrenia
KrzyΕciak, W., Szwajca, M., Εmierciak, N., Skalniak, A., Popiela, T.
Scientific Reports (2024), 14(1), 5755
π¬ Citations: 1 - Association of Blood Metabolomics Biomarkers with Brain Metabolites and Patient-Reported Outcomes as a New Approach in Individualized Diagnosis of Schizophrenia
KrzyΕciak, W., Bystrowska, B., Karcz, P., Popiela, T., Pilecki, M.
International Journal of Molecular Sciences (2024), 25(4), 2294
π§ Citations: 0 - Modified Lactoperoxidase System as a Promising Anticaries Agent: In Vitro Studies on Streptococcus mutans Biofilms
Magacz, M., Alatorre-SantamarΓa, S., KΔdziora, K., PamuΕa, E., KrzyΕciak, W.
International Journal of Molecular Sciences (2023), 24(15), 12136
π¦· Citations: 1 - Benefits and Meaning of Lipids Profile in Relation to Oxidative Balance and Brain Morphology in Schizophrenia
Εmierciak, N., KrzyΕciak, W., Szwajca, M., Aleksandrovych, V., Pilecki, M.
International Journal of Molecular Sciences (2023), 24(14), 11375
𧬠Citations: 3 - The Association of the Oral Microbiota with the Effects of Acid Stress Induced by an Increase of Brain Lactate in Schizophrenia Patients
KrzyΕciak, W., Karcz, P., Bystrowska, B., Popiela, T.J., Pilecki, M.
Biomedicines (2023), 11(2), 240
𧫠Citations: 4 - Safety Assessment of the Modified Lactoperoxidase SystemβIn Vitro Studies on Human Gingival Fibroblasts
Magacz, M., PapieΕΌ, M., KoΕcielniak, D., PamuΕa, E., KrzyΕciak, W.
International Journal of Molecular Sciences (2023), 24(3), 2640
π§ͺ Citations: 2 - Risk Factors for Weight Gain in Patients with First-Episode Psychosis
Batko, B., Szwajca, M., Εmierciak, N., Turek, A., Pilecki, M.
Psychiatria Polska (2023), 57(1), pp. 51β64
ποΈ Citations: 1 - Immunological Routine Laboratory Parameters at Admission Influence the Improvement of Positive Symptoms in Schizophrenia Patients After Pharmacological Treatment
Skalniak, A., KrzyΕciak, W., Εmierciak, N., Kozicz, T., Pilecki, M.
Frontiers in Psychiatry (2023), 14, 1082135
π Citations: 4 - Effect of a Short-Term Intervention with Lactobacillus salivarius Probiotic on Early Childhood CariesβAn Open Label Randomized Controlled Trial
Staszczyk, M., Jamka-Kasprzyk, M., KoΕcielniak, D., KrzyΕciak, W., Jurczak, A.
International Journal of Environmental Research and Public Health (2022), 19(19), 12447
πΆ Citations: 11